Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617926 · ClinicalTrials.gov registry record · NA
A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.
A NA study of Head Lice and Pediculosis Capitis, sponsored by Oystershell.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT03617926: Completed NA study of Head Lice and Pediculosis Capitis, sponsored by Oystershell.
NCT03617926 is a NA study of Head Lice and Pediculosis Capitis that has completed, run by Oystershell. The registered enrollment target is 70 participants, below the 103-participant average among 5 other Head Lice trials with a reported enrollment target (32% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03617926, a NA study of Head Lice and Pediculosis Capitis, has completed, sponsored by Oystershell.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
The present study is set-up to compare in vivo clinical performance and safety of the test product versus an in the US commercially available, pyrethrum-based product (RID® shampoo).
Primary Outcome
Clinical efficacy is reflected by the % of subjects that are lice-free after 2 topical applications (at day 0 \& day 7 respectively) of the test product. In this analysis, all baseline infestations (mild, moderate, severe) have been included. Assessment is performed at study end (visit 4, day 10). A mild infestation corresponds to 5-9 lice and/or nymphs A moderate infestation corresponds to 10-24 lice and/or nymphs A severe infestation corresponds to 25 or more lice and/or nymphs
Conditions Studied
Interventions
- DEVICE X92001666
- OTHER RID shampoo
Study Locations (2)
Florida
- South Fla. Family Health & Research Ctr.LLC - Miami
- Lice Source Services, Inc. - Plantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT03617926 record still lists
NCT03617926 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 103-participant average among 5 other Head Lice trials with a reported enrollment target (32% lower).
The record links to 2 conditions, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which X92001666 is the first listed.
NCT03617926 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03617926 about?
NCT03617926 is a clinical study titled "A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.". The present study is set-up to compare in vivo clinical performance and safety of the test product versus an in the US commercially available, pyrethrum-based product (RID® shampoo).
What is the current status of trial NCT03617926?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2018-03-07. Estimated completion is 2018-06-30.
What conditions does trial NCT03617926 study?
This clinical trial studies the following conditions: Head Lice, Pediculosis Capitis.
What interventions are being tested in trial NCT03617926?
The interventions under investigation include: X92001666 (DEVICE), RID shampoo (OTHER).
Who is sponsoring clinical trial NCT03617926?
This trial is sponsored by Oystershell, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617926 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Lice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Efficacy of Head-lice Treatments Elimax Green Lotion and Walgreens Lice Killing Shampoo
RECRUITING · NA
-
Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
COMPLETED · NA
-
Pediatric Head Lice Study Product Comparison
COMPLETED · Phase 2
-
Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects
COMPLETED · Phase 2
-
A Pilot Dose Ranging Study of Spinosad Creme Rinse
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI